Committed to helping you achieve your best research results
In addition to our technical Support team, we offer a variety of resources to enhance and inform your experience with the CellRaft technology and the AIR system.
Whether you’re interested in the latest scientific research using our products, or looking for tips and best practices for your own research, you’ll find a wealth of information here.
Papers & Publications – Review publications using the CellRaft technology for demonstrations of the various uses for the CellRaft AIR System and our CellRaft Arrays.
Webinars – Cell Microsystems offers a number of webinars featuring the CellRaft technology and applications to various research, including CRISPR, genome editing and single cell sorting and analysis..
Brochures – Looking for more information on our CellRaft AIR System or CellRaft Arrays? Download one of our brochures for more details.
Manuals – Manuals for our CellRaft AIR System and CellRaft Arrays describe the features and methods for use of each respective product. You can download them here.
Raft Notes – RaftNotes are applications and protocols for use with the CellRaft Technology. These publications cover materials and methods, tips, tricks, examples, and unique array formats that help our users achieve their best research results.
Patents – Cell Microsystems actively pursues patent protection for its innovative products and methods of using them.
Need Technical Support?
Recent Blog Posts
Advanced Therapy Medicinal Products – FDA recommended pathways for manufacturers and need for single cell cloning
The U.S. Food and Drug Administration (FDA) established the Office of Tissues and Advanced Therapies (OTAT) to oversee the development and regulation of advanced therapy medicinal products (ATMPs). (ATMPs are a class of medicinal products that include gene therapies, cell therapies, and tissue-engineered products.) OTAT works with other
Advancing Breast Cancer Drug Discovery with a Rare Double Positive Clone
The World Health Organization stated that as of 2020, nearly 8 million women alive were diagnosed with breast cancer in the last 5 years, making it the world’s most prevalent cancer (Retrieved from WHO). Globally, 1 in 8 women will be affected at some point during their lives with breast
Customer Spotlight: Accelerating Organoid Development
IPSCs and organoids offer a powerful platform for modeling disease & drug discovery. These models can deliver accurate insights which cannot be provided by immortalized cell lines or primary cells and are not subject to limitations of animal models. Notable disease models have been developed for cystic fibrosis, Alzheimer’s disease,
